| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.21 | 9e-05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |